This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
This brief explainer covers why the Dow Jones uses price weighting, its impact on index movements, and practical considerations for investors evaluating the index.
25,369 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
Investors often chase growth or income. When Enbridge trades under $60, a thoughtful plan can unlock both. This guide...
Ripple's private business shows strong growth while XRP trades near a $1 price. This article builds a practical, evid...
Nvidia sits at the center of AI-driven growth. This guide examines potential price paths for what will nvidia stock's...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...